Introducing the Tachyon Guardian, an AI-driven gene expression-based POC diagnostic platform designed for the Defence industry. Specialising in biodosimetry, it revolutionises radiological incident response by enhancing triage efficiency and predicting acute radiation syndrome outcomes. The Tachyon Guardian ensures rapid, accurate assessments, safeguarding personnel and civilians in high-stakes radiological emergencies.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Prototype
Technology Readiness Level: TRL 5
Organization Type: Early-stage Startup (Seed)
Market Keywords: point-of-care, Biodosimetry Triage Solutions, Acute Radiation Syndrome Prediction